Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyroid hormones for imaging outcomes in relapsing-remitting multiple sclerosis relapse
IRCT201210051859N6Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liothyronine and methylprednisolone in multiple sclerosis (MS), sponsored by Tehran University of Medical Sciences. Started Feb 2013; status: completed.
02
Drugs
liothyroninemethylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT201210051859N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201210051859N6.